What's inside
This standard operating procedure is fully drafted and structured, ready to brand and complete for your service. It covers:
- 1. Purpose
- 2. Scope
- 3. Definitions
- 4. Responsibilities
- 5. When screening is performed
- 6. Conditions to screen for, recommended tools and action thresholds
- 7. Physical health and cardiovascular screening before pharmacological treatment
- 8. Managing a positive screen
- 9. Escalation pathways and thresholds
- 10. Urgent risk and crisis management
- 11. Documentation
- 12. Communication with the GP and shared care
- 13. Remote and telehealth considerations
- 14. Training and competence
- 15. Audit and monitoring
- 16. Related documents
- 17. Document control and review
Legislation & standards it maps to
- NICE NG87 – Attention deficit hyperactivity disorder: diagnosis and management
- NICE CG133 – Self-harm (and NICE NG225 Self-harm: assessment, management and preventing recurrence)
- Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, Regulation 12 (Safe care and treatment)
- CQC single assessment framework
- General Medical Council – Good medical practice (2024)
- Mental Health Act 1983 (as amended)
- Safeguarding Vulnerable Groups Act 2006
- Medicines and Healthcare products Regulatory Agency (MHRA) guidance on methylphenidate and cardiovascular safety
- British National Formulary (BNF) – central nervous system stimulants and ADHD
Who it applies to
All assessing and prescribing clinicians, clinical staff and [Clinical Lead] at [Organisation Name].
How it works
- Buy securely with Stripe - instant, no VAT, no account needed.
- Download your editable Word file from the link we email you straight away.
- Complete the placeholders for your service, then have it approved before use.
- Add the optional updates subscription and we keep it current as guidance changes.